Search results - 9 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
Burden and Impact Studies (VEBIS) project. A retrospective cohort was constructed from linked electronic health records (EHR) in each country. Countryspecific (level) relative VE (rVE) was estimated on ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
COVID-19 infection were more likely to receive the first booster. For the second booster, the same age trend was seen as for the first booster. Males, individuals residing in Flanders and those who tested ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
using electronic health registries (EHR), between October 2021 and November 2022, in community-dwelling residents aged 65-79 and ≥80 years in six European countries. METHODS: EHR linkage was used to ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
COVID-19 was rolled out to the adult population in Belgium, followed by the first booster campaign towards the end of the year. At the beginning of 2022, booster doses were recommended and offered to people ...
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
Interferon-gamma Interleukin-2 mice Vaccination Vaccines, DNA Abstract: C57BL /6 mice were vaccinated with plasmid DNA encoding Ag85 from Mycobacterium tuberculosis, with Ag85 protein in adjuvant, or with a combined ...
Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
a DNA vaccine encoding Ag85A from Mycobacterium tuberculosis were compared in BALB /c and C57BL (B6 and B10) mice immunized by intramuscular (i.m.) needle injection or epidermal gene gun (gg) bombardment. ...
Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.
Infect. Immun. 61:2687-2693, 1993). These monoclonal antibodies were used to screen an M. bovis BCG genomic library made in phage lambdagt11. The gene encoding a 233-amino-acid (aa) protein, including ...
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.
types of Ag85A- DNA vaccines; those expressing secreted and non-secreted forms of the protein. DESIGN: Ag85A- DNA vaccinated mice were challenged with a highly virulent clinical isolate of M. tuberculosis ...
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
Mice, Inbred BALB C Mice, Inbred C57BL Mycobacterium bovis T-Lymphocytes, Cytotoxic Th1 Cells Tuberculosis Vaccines, DNA Abstract: BALB /c and C57BL /6 mice were injected intramuscularly with plasmid DNA ...